Immune Pharmaceuticals, Inc. (IMNP) announced today positive results from a mouse study demonstrating that blockade of eotaxin-1 reduces lung inflammation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE